Home

PALVELLA THERAPEUTICS, INC.

CIK 1583648 · Chief Scientific Officer · last filed 2025-02-07

PALVELLA THERAPEUTICS, INC. is a Chief Scientific Officer who has filed 4 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for PVLA, was dated Feb 7, 2025. The firm reports its address in Wayne, PA. 25 SEC filings were submitted jointly with Kathleen Goin.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

4

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
353 W. LANCASTER AVENUE
SUITE 200
WAYNE, PA 19087
Phone
(484) 253-1461
State of Incorporation
NV
Formerly Known As
PIERIS PHARMACEUTICALS, INC. (2014–2024)
Marika Inc. (2013–2014)
Related Filers
Kathleen Goin — 25 joint filings, latest 2026-08-20
Michael Richman — 25 joint filings, latest 2023-06-23
BIOTECHNOLOGY VALUE FUND L P — 24 joint filings, latest 2026-08-14
CHRISTOPHER P KIRITSY — 19 joint filings, latest 2026-09-02
ORBIMED ADVISORS LLC — 16 joint filings, latest 2018-09-27
JAMES A GERAGHTY — 14 joint filings, latest 2024-12-12
Chau Quang Khuong — 13 joint filings, latest 2017-10-27
Stephen S. Yoder — 10 joint filings, latest 2023-02-28
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PVLA Chief Scientific Officer — $149.56 — $0 4 2025-02-07

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-02-07 PVLA Grant (A) — $0 EDGAR
2025-02-07 PVLA Grant (A) — $0 EDGAR
2025-02-07 PVLA Grant (A) — $0 EDGAR
2025-02-07 PVLA Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.